TranXenoGen and U.S. Transgenics joint venture

TranXenoGen (Shrewsbury, Mass.) and U.S. Transgenics (Washington, D.C.) signed letters of intent to form a joint venture to develop recombinant human serum albumin (HSA) in the albumin fraction of tra...